Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cance... (nosed in the U.S. annually with the numb...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

Date:8/19/2007

nosed in the U.S. annually, with the number increasing over the past 20-30 years. Carcinoid tumors that metastasize to the liver have a poor prognosis. Traditionally, chemotherapy relieves symptoms in less than 30% of cases of metastatic carcinoid tumors, usually for less than 1 year. Carcinoid tumors typically produce a condition called "carcinoid syndrome" which is caused by the release of hormones by the tumors into the blood stream. The symptoms vary depending on which hormones are released by the tumors, but typically include diarrhea, facial flushing, wheezing, abdominal pain and valvular heart disease.

About Callisto Pharmaceuticals, Inc.

Callisto is a biopharmaceutical company focused on the development of new drugs to treat various forms of cancer and gastrointestinal diseases. Callisto's drug candidates in development currently include anti-cancer agents in clinical development, in addition to drugs in pre-clinical development for other significant health care markets, including gastrointestinal disorders. One of the Company's lead drug candidates, Atiprimod is presently in a Phase II clinical trial in advanced carcinoid cancer patients, a neuroendocrine tumor, and in a Phase I/IIa human clinical trial in relapsed or refractory multiple myeloma patients. Another anti-cancer drug, L-Annamycin, is being developed as a treatment for forms of relapsed or refractory acute leukemia, a currently incurable blood cancer. L-Annamycin is currently in a Phase I clinical trial in adult relapsed or refractory acute lymphocytic leukemia, and in a Phase I clinical trial in children and young adults with refractory or relapsed acute lymphocytic leukemia or acute myelogenous leukemia. L- Annamycin, a member of the anthracycline family of proven anti-cancer drugs, has a novel therapeutic profile, including potential activity against multi- drug resistant tumors and significantly reduced cardiotoxicity, or damage to the heart, compared to currently available drug
'/>"/>

SOURCE Callisto Pharmaceuticals, Inc.

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Callisto Pharmaceuticals Announces Publication of Research Article on Atiprimod Preclinical Studies in Mantle Cell Lymphoma
2. Callisto Intends to Move Guanilib into Clinical Trials in Ulcerative Colitis
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea

Post Your Comments:

[0] Pharmacy Technician Employment Increasing Up to 32% By 2016 [0] Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia [0] Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia

Other Medicine Technology:Complications and Costs for Obesity Surgery Declining 2 USAID Provides $5M in Emergency Support as Swine Flu Spreads 2

Complications and Costs for Obesity Surgery Declining USAID Provides $5M in Emergency Support as Swine Flu Spreads

Breaking Medicine News(10 mins):Health News:Lead Exposure May Affect Mental Health 2 Health News:ASGE issues guidelines on management of antithrombotic agents for endoscopic procedures 2 Health News:ASGE issues guidelines on management of antithrombotic agents for endoscopic procedures 3 Health News:ASGE issues guidelines on management of antithrombotic agents for endoscopic procedures 4 Health News:ASGE issues guidelines on management of antithrombotic agents for endoscopic procedures 5 Health News:Injections Aren't Solution for Retained Placenta: Study 2 Health News:Abortion, Bishops, and Healthcare: Announcing 'Deaf at the Cathedral' Tour in Nine States. 2 Health News:BHR Pharma Files Investigational New Drug Application, Receives Orphan Drug Designation, for Traumatic Brain Injury Treatment 2

[0] Lead Exposure May Affect Mental Health [0] ASGE issues guidelines on management of antithrombotic agents for endoscopic procedures [0] Injections Aren't Solution for Retained Placenta: Study [0] Abortion, Bishops, and Healthcare: Announcing 'Deaf at the Cathedral' Tour in Nine States.[0] BHR Pharma Files Investigational New Drug Application, Receives Orphan Drug Designation, for Traumatic Brain Injury Treatment

Other Medicine News:Health News:"Viral Campaign May Lead to Guinness World Record" 2 Health News:Hiawatha Community Hospital Brings Medication Safety to the Bedside With IntelliDOT Barcode Point-of-Care System 2 Health News:Hiawatha Community Hospital Brings Medication Safety to the Bedside With IntelliDOT Barcode Point-of-Care System 3 Health News:Hiawatha Community Hospital Brings Medication Safety to the Bedside With IntelliDOT Barcode Point-of-Care System 4 Health News:Top 10 Ingredients for Recession-Proof, Healthy Cooking 2 Health News:Top 10 Ingredients for Recession-Proof, Healthy Cooking 3 Health News:YMCA Helps Community Members Tackle Economic Stress 2 Health News:The Cooper Institute and UT Southwestern Announce Medical Research Collaboration 2 Health News:Isabelle Simon Joins Publicis Groupe as Senior Vice President 2

"Viral Campaign May Lead to Guinness World Record"Hiawatha Community Hospital Brings Medication Safety to the Bedside With IntelliDOT Barcode Point-of-Care System Top 10 Ingredients for Recession-Proof, Healthy Cooking YMCA Helps Community Members Tackle Economic Stress The Cooper Institute and UT Southwestern Announce Medical Research Collaboration Isabelle Simon Joins Publicis Groupe as Senior Vice President

Medicine Products:

FDP80 Oil Vacuum Pump for Freeze Drying QIAvac Multiwell Vac-Man® Jr. Laboratory Vacuum Manifold, 2-sample capacity Perfect Single basic Vac Manifold

Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cance...(nosed in the U.S. annually with the numb...),Health